Tokushima University / Educator and Researcher Directory --- Yoshida, Kanako

Field of Study

○	Medicine

Subject of Study

○

Book / Paper

Book:

1.	山本由理, Takeshi Katou, 炬口恵理, Kanako Yoshida, Yuu Tanaka, Takashi Kaji, Satoshi Yamamoto, Akira Kuwahara and Minoru Irahara : 抗NMDAR(N-methy-D-aspartate receptor)脳炎をきたした卵巣成熟奇形腫の一例, Sep. 2010.

Academic Paper (Judged Full Paper):

1.	Yoshie Imai, Yuka Mori, 御手洗幸子, 入澤裕子, 大川恵, 日下咲, 下川亜矢, 納富理絵, 松本仁美, Akiko Abe, Kanako Yoshida, 村上好恵, 武田祐子, 川崎優子 and 阪本朋香 : International Trends in Decision-making Regarding Risk-reducing Salpingo-oophorectomy for Hereditary Breast and Ovarian Cancer Syndrome, Shikoku Acta Medica, Vol.75, No.5,6, 245-252, 2024. (Keyword) recurrence and metastasis / lung cancer patient / prospect (Link to Publication Site) ● Publication site (DOI): 10.57444/shikokuactamedica.79.5.6_245 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390862566410144512 ● Search Scopus @ Elsevier (DOI): 10.57444/shikokuactamedica.79.5.6_245 (DOI: 10.57444/shikokuactamedica.79.5.6_245, CiNii: 1390862566410144512)
2.	Ayako Suto, Yuya Yano, Yuri Yamamoto, Hiroki Noguchi, Asuka Takeda, Shota Yamamoto, Tomohiro Kagawa, Kanako Yoshida, Kenji Hinokio, Akira Kuwahara, Toshiyuki Yasui and Takeshi Iwasa : Effects of activation with a Ca ionophore and roscovitine on the development of human oocytes that failed to fertilize after ICSI., The Journal of Medical Investigation : JMI, Vol.70, No.3.4, 321-324, 2023. (Summary) Sequential treatment with an Ca ionophore and roscovitine activates oocytes that remain unfertilized after ICSI. In TESE-ICSI, the activation rate tended to be increased by the co-administration of roscovitine with a Ca ionophore. J. Med. Invest. 70 : 321-324, August, 2023. (Keyword) Humans / male / Ionophores / Sperm Injections, Intracytoplasmic / Roscovitine / Semen / Oocytes (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.70.321 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 37940514 ● Search Scopus @ Elsevier (PMID): 37940514 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.70.321 (DOI: 10.2152/jmi.70.321, PubMed: 37940514)
3.	Takako Kawakita, Takeshi Kato, Yuri Kadota, Aya Shirakawa, Riyo Kinouchi, Kanako Yoshida and Takeshi Iwasa : Approach to medical education using laparoscopic simulator in covid-19 pandemic, Shikoku Acta Medica, Vol.79, No.1.2, 103-108, 2023. (Keyword) COVID-19 / medical education / laparoscopy / simulator (Link to Publication Site) ● Publication site (DOI): 10.57444/shikokuactamedica.79.1.2_103 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390015191534389248 ● Search Scopus @ Elsevier (DOI): 10.57444/shikokuactamedica.79.1.2_103 (DOI: 10.57444/shikokuactamedica.79.1.2_103, CiNii: 1390015191534389248)
4.	Yoshie Imai, Akiko Abe, 村上好恵, 武田祐子, 川崎優子, Takae Bando, Aki Takahashi, Yuta Inoue, 阪本朋香 and Kanako Yoshida : Emotions of patients with hereditary breast and ovarian cancer syndrome after risk reducing salpingo-oophorectomy, Journal of Hereditary Tumors, Vol.22, No.3, 68-74, 2022. (Keyword) 乳癌患者 / 遺伝性乳癌卵巣癌症候群患者 / リスク低減卵管卵巣摘出術 / breast cancer patients / hereditary breast and ovarian cancer syndrome(HBOC) / risk reducing salpingo-oophorectomy (RRSO) (Link to Publication Site) ● Publication site (DOI): 10.18976/jsht.22.3_68 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390295138251540608 ● Search Scopus @ Elsevier (DOI): 10.18976/jsht.22.3_68 (DOI: 10.18976/jsht.22.3_68, CiNii: 1390295138251540608)
5.	Takako Kawakita, Toshiyuki Yasui, Kanako Yoshida, Sumika Matsui and Takeshi Iwasa : Correlations of Androstenediol with Reproductive Hormones and Cortisol According to Stages during the Menopausal Transition in Japanese Women. J, The Journal of Steroid Biochemistry and Molecular Biology, Vol.214, 106009, 2021. (Summary) Associations of androstenediol, which has both androgenic and estrogenic activities, with circulating reproductive hormones and stress hormone in women during the menopausal transition may be different depending on the menopausal stage. The aim of this study was to determine the changes in circulating androstenediol during the menopausal transition in Japanese women and the associations of androstenediol with estrogen, androgen and cortisol for each stage of the menopausal transition. We divided the 104 subjects into 6 stages by menstrual regularity and follicle-stimulating hormone level: mid reproductive stage, late reproductive stage, early menopausal transition, late menopausal transition, very early postmenopause and early postmenopause. Levels of dehydroepiandrosterone sulfate (DHEAS), estradiol, estrone, testosterone (T), free T, androstenedione and cortisol were measured. Serum androstenediol concentration was measured by using liquid chromatography mass spectrometry. There were no significant differences in androstenediol levels among the 6 stages. Levels of DHEA-S and testosterone showed significant and positive correlations with androstenediol in all stages. Estradiol levels showed negative correlations with androstenediol levels in the late menopausal transition and very early postmenopause (r=-0.452, p = 0.052 and r=-0.617, p = 0.006, respectively). Cortisol levels showed significant and positive correlations with androstenediol levels in the mid and late reproductive stages (r = 0.719, p = 0.003 and r = 0.808, p < 0.001, respectively).The associations of androstenediol with estradiol and cortisol were different depending on the stage of the menopausal transition. Androstenediol may play a compensatory role for estrogen deficiency from late menopausal transition to very early postmenopause. (Keyword) Adult / Androgens / Androstenediol / Androstenedione / Cross-Sectional Studies / Dehydroepiandrosterone Sulfate / Estradiol / Estrogens / female / Humans / Hydrocortisone / Japan / Menopause / Outpatients / Postmenopause / Testosterone (Link to Publication Site) ● Publication site (DOI): 10.1016/j.jsbmb.2021.106009 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 34571175 ● Search Scopus @ Elsevier (PMID): 34571175 ● Search Scopus @ Elsevier (DOI): 10.1016/j.jsbmb.2021.106009 (DOI: 10.1016/j.jsbmb.2021.106009, PubMed: 34571175)
6.	Takako Kawakita, Takeshi Iwasa, Shuhei Kamada, Kanako Yoshida and Takeshi Katou : Effects of gonadal status and the estrogen milieu on hypothalamic oxytocin gene expression and serum oxytocin levels in female rats., Hormones and Behavior, Vol.133, No.8, 105005, 2021. (Summary) Oxytocin (OT) and its receptor (OTR) play various roles in the central and peripheral regulation of appetite and body weight. Previously, we have shown that the administration of OT markedly decreased appetite and body weight gain in ovariectomized (OVX) obese rats. In addition, recent studies have shown that the endogenous OT system is also affected by endogenous or exogenous estrogen. In this study, we showed that ovariectomy decreased rats' hypothalamic OT/OTR mRNA and serum OT levels, but did not affect their visceral fat OTR mRNA levels. The chronic administration of estradiol (E2) abrogated these ovariectomy-induced changes; i.e., it increased the rats' hypothalamic OT/OTR mRNA and serum OT levels, and may be associated with reductions in food intake and body weight gain. In addition, acute E2 administration increased the rats' hypothalamic OTR mRNA and serum OT levels, but did not affect their hypothalamic OT mRNA levels. Taken together, these results suggest that endogenous OT and/or OTR expression might be positively regulated by E2 and that the suppressive effects of E2 on appetite and body weight gain might be mediated, at least in part, by the OT system. Thus, we consider that OT might be a target hormone to pursue subsequent interventions of menopause for menopause-induced metabolic disorders. (Keyword) Animals / Estradiol / Estrogens / Female / Gene Expression / Humans / Ovariectomy / Oxytocin / Rats / Rats, Sprague-Dawley / Receptors, Oxytocin (Tokushima University Institutional Repository) ● Metadata: 116889 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.yhbeh.2021.105005 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 34116458 ● Search Scopus @ Elsevier (PMID): 34116458 ● Search Scopus @ Elsevier (DOI): 10.1016/j.yhbeh.2021.105005 (Tokushima University Institutional Repository: 116889, DOI: 10.1016/j.yhbeh.2021.105005, PubMed: 34116458)
7.	Kana Kasai, Takeshi Katou, Yuri Kadota, Otgontsetseg Erdenebayar, Kaoru Keyama, Takako Kawakita, Kanako Yoshida, Akira Kuwahara, Toshiya Matsuzaki and Minoru Irahara : Intraperitoneal administration of activin A promotes development of endometriotic lesions in a mouse model of endometriosis., The Journal of Medical Investigation : JMI, Vol.66, No.1.2, 123-127, 2019. (Summary) This study aimed to investigate the effect of intraperitoneal administration of activin on the occurrence of endometriosis using a mouse model of endometriosis. A mouse model of endometriosis was prepared by intraperitoneally administering endometrial tissue and blood collected from donor mice to C57BL/6J 7-8- week-old recipient mice. A total of 400 μg of activin A was intraperitoneally administered to model mice in the activin group for 5 days. Intraperitoneal endometriotic lesions were confirmed macroscopically and IL-6 and TNF-α levels in washed ascites were measured by ELISA. Endometriotic lesions were observed in all mice. In the activin group, the maximum diameter of endometriotic lesions was significantly larger than that in control group (4.7?1.3 vs 2.9?0.9 mm, p?0.01). The total area of the lesion was also significantly higher in the activin group than in the control group (21.1?9.9 vs 8.8?5.4 mm,p?0.01). Furthermore, IL-6 and TNF-α levels in ascites were significantly higher in the activin group than in the control group (IL-6 : 85.8?15.3 vs 75.1?19.3 pg/ml, p?0.05 ; TNF-α : 629.8?15.4 vs 605.9?11.4 pg/ml, p?0.05). Activin promotes occurrence of endometriosis. Inflammatory cytokines are also elevated by activin administration,suggesting that they may contribute to progression of endometriosis J. Med. Invest. 66 : 123-127, February, 2019. (Tokushima University Institutional Repository) ● Metadata: 113270 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.66.123 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 31064924 ● Search Scopus @ Elsevier (PMID): 31064924 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.66.123 (Tokushima University Institutional Repository: 113270, DOI: 10.2152/jmi.66.123, PubMed: 31064924)
8.	Kaoru Keyama, Takeshi Katou, Yuri Kadota, Otgontsetseg Erdenebayar, Kana Kasai, Takako Kawakita, Anna Tani, Sumika Matsui, Takeshi Iwasa, Kanako Yoshida, Masahiko Maegawa, Akira Kuwahara, Toshiya Matsuzaki and Minoru Irahara : Lipopolysaccharide promotes early endometrial-peritoneal interactions in a mouse model of endometriosis., The Journal of Medical Investigation : JMI, Vol.66, No.1.2, 70-74, 2019. (Summary) The aims of this study were to clarify the effects of lipopolysaccharide (LPS) on the early development of endometriosis and on the production of cytokines and chemokines in the murine peritoneal cavity. Endometriotic lesions were induced in C57BL/6J adult female mice by intraperitoneal injection of endometrial fragments plus blood or endometrial fragments plus blood with LPS. On day 7, endometriotic lesions were assessed by gross and microscopic evaluations. Time-dependent changes in the secretion of TNF-α,IL-6,and CXCL2/MIP-2 in peritoneal lavage fluid after the intraperitoneal injection of LPS (50 µg/body) were measured by their respective enzyme-linked immunosorbent assays. The areas of endometriotic lesions in the LPS group (10.8 8.6 mm) were significantly larger than those in the control group (3.1 3.7 mm).The levels of TNF-α and IL-6 peaked within 2 hours and the level of MIP-2 reached a maximum on day 1 after the injection of LPS. LPS promotes development of the early stages of murine endometriotic lesions. J. Med. Invest. 66 : 70-74, February, 2019. (Tokushima University Institutional Repository) ● Metadata: 113324 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.66.70 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 31064958 ● Search Scopus @ Elsevier (PMID): 31064958 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.66.70 (Tokushima University Institutional Repository: 113324, DOI: 10.2152/jmi.66.70, PubMed: 31064958)
9.	Kanako Yoshida, Masato Nishimura, Akiko Abe, Takeshi Katou, Hiroyuki Furumoto and Minoru Irahara : Can systematic lymphadenectomy be omitted for low-risk endometrial cancer?, The Journal of Medical Investigation : JMI, Vol.65, No.3,4, 221-224, 2018. (Summary) The objective of this study was to identify pathological indicators that could be used to identify a subgroup of patients with apparent stage I endometrial cancer who do require retroperitoneal lymphadenectomy. 188 T1 endometrial cancer patients underwent primary surgery at Tokushima University Hospital. We retrospectively evaluated their clinical records and histopathological factors. Systematic lymphadenectomy was performed for 149 patients, and 39 patients (grade 1 with < 5 mm of myometrial invasion) were treated without lymphadenectomy. Lymph node metastases were found in 19 (12.8%) of the lymphadenectomy cases. Twenty-four patients with a T1a endometrium-limited lesion did not exhibit lymph node metastasis. Three (3.1%) of the 95 patients with a T1a lesion exhibited lymph node metastasis, and these 3 cases exhibited approximately 50% myometrial invasion. The 39 low-risk patients who did not undergo systematic lymphadenectomy remain alive without recurrence. Systematic lymphadenectomy could be omitted for patients with a grade 1 tumor and minor myometrial invasion of less than 5mm. J. Med. Invest. 65:221-224, August, 2018. (Keyword) Adult / Aged / Aged, 80 and over / Endometrial Neoplasms / Female / Humans / Lymph Node Excision / Lymphatic Metastasis / Middle Aged / Myometrium / Neoplasm Staging / Retrospective Studies / Risk Factors / Young Adult (Tokushima University Institutional Repository) ● Metadata: 112242 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.65.221 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 30282864 ● Search Scopus @ Elsevier (PMID): 30282864 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.65.221 (Tokushima University Institutional Repository: 112242, DOI: 10.2152/jmi.65.221, PubMed: 30282864)
10.	Sumika Matsui, Toshiyuki Yasui, Kana Kasai, Kanako Yoshida, Takeshi Katou, Hirokazu Uemura, Akira Kuwahara, Toshiya Matsuzaki and Minoru Irahara : Circulating dehydroepiandrosterone-sulphate decreases even with a slight change in oestradiol., Journal of Obstetrics and Gynaecology, Vol.38, No.2, 231-235, 2017. (Summary) The aim of this study was to determine the effect of hormone replacement therapy (HRT) on changes in circulating dehydroepiandrosterone-sulphate (DHEA-S) with focus on the relationship between oestrogen level and change in DHEA-S. Forty-two women were enrolled in this longitudinal study. Nineteen women received oral oestradiol and twenty-three women received transdermal oestradiol continuously. Twenty women received progesterone continuously except for women who had undergone hysterectomy. Circulating oestradiol, follicle-stimulating hormone, luteinising hormone and DHEA-S levels before and at 3 months after commencement of HRT were measured. Circulating DHEA-S level was significantly decreased at 3 months (p < .001). Oestradiol level at 3 months ranged from 6.5 pg/ml to 159 pg/ml. There was no significant correlation of ΔDHEA-S (DHEAS level at 3 months-DHEA-S level at baseline) with Δoestradiol (r = 0.114, p = .471). Circulating DHEA-S level was significantly decreased at 3 months in all the four quartiles and divided according to Δoestradiol, and ΔDHEA-S did not show significant differences. In conclusion, circulating DHEA-S decreases even with a slight increase in oestradiol level. Impact statement What is already known on this subject: A transient increase in DHEA-S in women during the menopausal transition may be involved in the occurrence of menopausal symptoms and/or unfavourable metabolic changes. Hormone replacement therapy decreases circulating DHEA-S level. However, dose dependency of the change in DHEA-S on oestrogen has not been reported. What the results of this study add: Circulating DHEA-S decreases even with a slight increase in oestradiol level. What the implications are of these findings for clinical practice and/or further research: Adrenal function may respond to a small change in oestrogen. (Link to Publication Site) ● Publication site (DOI): 10.1080/01443615.2017.1344829 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 28903616 ● Search Scopus @ Elsevier (PMID): 28903616 ● Search Scopus @ Elsevier (DOI): 10.1080/01443615.2017.1344829 (DOI: 10.1080/01443615.2017.1344829, PubMed: 28903616)
11.	Sumika Matsui, Toshiyuki Yasui, Kana Kasai, Kaoru Keyama, Kanako Yoshida, Takeshi Katou, Hirokazu Uemura, Akira Kuwahara, Toshiya Matsuzaki and Minoru Irahara : Sex hormone-binding globulin and antithrombin III activity in women with oral ultra-low-dose estradiol., Journal of Obstetrics and Gynaecology, Vol.37, No.5, 627-632, 2017. (Summary) Oral oestrogen increases the risk of venous thromboembolism (VTE) and increases production of sex hormone-binding globulin (SHBG) in a dose-dependent manner. SHBG has been suggested to be involved in venous thromboembolism. We examined the effects of oral ultra-low-dose oestradiol on circulating levels of SHBG and coagulation parameters, and we compared the effects to those of transdermal oestradiol. Twenty women received oral oestradiol (500 g) every day (oral ultra-low-dose group) and 20 women received a transdermal patch (50 g) as a transdermal group. In addition, the women received dydrogesterone continuously (5g) except for women who underwent hysterectomy. Circulating SHBG, antithrombin III (ATIII) activity, d-dimer, thrombin-antithrombin complex and plasmin- 2 plasmin inhibitor complex were measured before and 3 months after the start of treatment. SHBG was significantly increased at 3 months in the oral ultra-low-dose group, but not in the transdermal group. However, percent changes in SHBG were not significantly different between the two groups. In both groups, ATIII was significantly decreased at 3 months. In conclusion, even ultra-low-dose oestradiol orally increases circulating SHBG level. However, the magnitude of change in SHBG caused by oral ultra-low-dose oestradiol is small and is comparable to that caused by transdermal oestradiol. Impact statement Oral oestrogen replacement therapy increases production of SHBG which may be related to increase in VTE risk. However, the effect of oral ultra-low-dose oestradiol on SHBG has not been clarified. Even ultra-low-dose oestradiol orally increases circulating SHBG levels, but the magnitude of change in SHBG caused by oral ultra-low-dose oestradiol is small and is comparable to that caused by transdermal oestradiol. VTE risk in women receiving oral ultra-low-dose oestradiol may be comparable to that in women receiving transdermal oestradiol. (Link to Publication Site) ● Publication site (DOI): 10.1080/01443615.2017.1285275 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 28317410 ● Search Scopus @ Elsevier (PMID): 28317410 ● Search Scopus @ Elsevier (DOI): 10.1080/01443615.2017.1285275 (DOI: 10.1080/01443615.2017.1285275, PubMed: 28317410)
12.	Takeshi Katou, Kaoru Keyama, Sumika Matsui, Mikio Yamasaki, Kanako Yoshida and Minoru Irahara : Step Up from Salpingo-Oophorectomy to Total Laparoscopic Hysterectomy Incorporating Incision Dissectiong Procedures., Journal of Minimally Invasive Gynecology, Vol.22, No.6S, S217, 2015. (Link to Publication Site) ● Publication site (DOI): 10.1016/j.jmig.2015.08.772 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 27679084 ● Search Scopus @ Elsevier (PMID): 27679084 ● Search Scopus @ Elsevier (DOI): 10.1016/j.jmig.2015.08.772 (DOI: 10.1016/j.jmig.2015.08.772, PubMed: 27679084)
13.	Yasuyo Saijo, Hiroyuki Furumoto, Kanako Yoshida, Masato Nishimura and Minoru Irahara : Clinical Significance of Vascular Endothelial Growth Factor Expression and Microvessel Density in Invasive Cervical Cancer., The Journal of Medical Investigation : JMI, Vol.62, No.3-4, 154-160, 2015. (Summary) To determine whether vascular endothelial growth factor (VEGF) expression and microvessel density are predictive of prognosis in cases of invasive cervical cancer, correlations among VEGF expression, microvessel density, and clinicopathological parameters were identified. VEGF expression was evaluated in 50 cervical cancer samples by immunohistochemical staining. Microvessel density was assessed by immunostaining for CD31-positive endothelial cells in the most vascularized areas of tumors. VEGF expression and microvessel density were significantly higher in adenocarcinomas than in squamous cell carcinomas. However, in cases of adenocarcinoma, no significant correlations were found among VEGF expression, microvessel density, and clinicopathological parameters. In contrast, for squamous cell carcinomas, microvessel density was significantly higher in cases at an advanced stage and in those with several other poor prognostic factors. The finding that cervical adenocarcinomas exhibited greater VEGF expression and microvessel density than squamous cell carcinomas may explain the poorer prognosis of adenocarcinoma compared with squamous cell carcinoma. Moreover, microvessel density in squamous cell carcinomas was significantly correlated with poor prognostic factors. Therefore, there is possibility that bevacizumab, a humanized monoclonal antibody against VEGF-A, may be useful in the initial treatment targeting angiogenesis for early-stage cervical cancer. (Tokushima University Institutional Repository) ● Metadata: 111271 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.62.154 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 26399340 ● Search Scopus @ Elsevier (PMID): 26399340 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.62.154 (Tokushima University Institutional Repository: 111271, DOI: 10.2152/jmi.62.154, PubMed: 26399340)
14.	河見貴子, Hiroyuki Furumoto, Kanako Yoshida, Takeshi Katou, Masato Nishimura and Minoru Irahara : Effectiveness and tolerability of hysterectomy for the local recurrence of cervical cancer after radiation therapy, Modern Trends in Obstetrics & Gynecology, Vol.61, No.2, 321-324, 2013. (Keyword) recurrent uterine cervical cancer / concurrent chemoradiation (CCRT) / hysterectomy (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520009409864859776 (CiNii: 1520009409864859776)
15.	東元あゆか, Takeshi Katou, Akiko Abe, 海老沢桂子, Kanako Yoshida, Masato Nishimura, Hiroyuki Furumoto and Minoru Irahara : 当院におけるプラチナ耐性再発卵巣癌に対するドキシルの使用経験, Modern Trends in Obstetrics & Gynecology, Vol.60, No.1, 173-177, 2011. (Keyword) ドキシル / 再発 / 卵巣癌 / Doxil (PLD) / recurrent / ovarian cancer / salvage chemotherapy (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520009409869175424 (CiNii: 1520009409869175424)
16.	Kanako Yoshida, Hiroyuki Furumoto, Akiko Abe, Takeshi Katou, Masato Nishimura and Minoru Irahara : The possibility of vertical transmission of human papillomavirus through maternal milk, Journal of Obstetrics and Gynaecology, Vol.31, No.6, 503-506, 2011. (Summary) Human papillomavirus (HPV) DNA has been detected in the oral cavity of infants and breast cancer tissue, suggesting its vertical transmission through maternal milk. We determined whether HPV is detected in maternal milk and is vertically transmitted by breast-feeding. Informed consent was obtained, and maternal milk samples (n=80) were analysed for high-risk HPV DNA. In 43 women, this DNA was measured in the uterine cervix. In women with positive samples, this DNA was measured in the oral cavities of their children. The domain including HPV E6 and E7 was amplified by polymerase chain reaction using consensus primers, and HPV serotype determined by electrophoresis after restriction enzyme digestion. High-risk HPV-16 was detected in two of 80 samples (2.5%), and in these two cases, high-risk HPV was not detected in the uterine cervix or oral cavity of the child. It was concluded that the infection of HPV in maternal milk is rare (2/80); vertical transmission through maternal milk was not detected in this study (0/80). HPV infection through maternal milk may occur, but its likelihood is low. (Keyword) Adult / Cervix Uteri / DNA Primers / DNA, Viral / Female / Human papillomavirus 16 / Humans / Infant / Infectious Disease Transmission, Vertical / Milk, Human / Mouth Mucosa / Papillomavirus Infections / Polymerase Chain Reaction (Tokushima University Institutional Repository) ● Metadata: 113613 (Link to Publication Site) ● Publication site (DOI): 10.3109/01443615.2011.570814 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 21823849 ● Search Scopus @ Elsevier (PMID): 21823849 ● Search Scopus @ Elsevier (DOI): 10.3109/01443615.2011.570814 (Tokushima University Institutional Repository: 113613, DOI: 10.3109/01443615.2011.570814, PubMed: 21823849)
17.	笠井可菜, Takeshi Katou, 谷口友香, Yuu Tanaka, Akiko Abe, 海老沢桂子, Kanako Yoshida, Hiroyuki Furumoto and Minoru Irahara : Leiomyomatosis peritonealis desseminata(LPD)の一例, Modern Trends in Obstetrics & Gynecology, Vol.59, No.2, 271-273, 2011. (Keyword) 腹膜播種性平滑筋腫症 / 多発性子宮筋腫 / Leiomyomatosis peritoneal Desseminata / LPD / multiple myoma (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520009409867105536 (CiNii: 1520009409867105536)
18.	Kanako Yoshida, Atsuko Hichijyo, Akiko Abe, 海老沢桂子, Takeshi Katou, Hiroyuki Furumoto and Minoru Irahara : 外陰のpapillary hidradenomaの1例, Modern Trends in Obstetrics & Gynecology, Vol.59, No.2, 221-224, 2011. (Keyword) 外陰 / 乳頭状汗腺腫 / Vulva / Papillary hiradenoma (Tokushima University Institutional Repository) ● Metadata: 113615 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1050020697876292608 (Tokushima University Institutional Repository: 113615, CiNii: 1050020697876292608)
19.	Akiko Abe, Hiroyuki Furumoto, Kanako Yoshida, Takeshi Katou, Yasuyo Saijo and Minoru Irahara : Gene gun-mediated skin transfection with FL gene suppresses the growth of murine fibrosarcoma., The Journal of Medical Investigation : JMI, Vol.58, No.1-2, 39-45, 2011. (Summary) Particle-mediated transfection is known as an efficient method of non-viral gene transfer. Flt3 ligand (FL) is a growth factor for hematopoietic progenitors; it promotes the growth of dendritic cells (DC). DCs are powerful antigen-presenting cells (APCs) and show a remarkable capacity to stimulate antigen-specific T-cell responses. In this study, we intended to investigate the suppressive effect on tumor growth by gene gun-mediated transfer of FL in a murine model. C57BL/6J mice were injected intradermally with MCA205 cells. DNA (pNGVL-hFLex)-coated gold particles were delivered to the mouse skin surrounding the target tumor. The expression of FL was determined by RT-PCR. Analyses by immunohistochemistry and fluorescence-activated cell sorter (FACS) revealed an increase in the number of DC after treatment with FL. Gene gun-mediated pNGVL-hFLex transfer significantly inhibited the growth of the MCA205 tumor. FL transfer markedly increased the number of CD11c(+) DCs in the tumor tissue. Further, the FL-transfected mice exhibited a significantly higher number of CD80(+) MHC-II cells. We successfully performed FL therapy using an in vivo gene gun in order to effectively mobilize DCs in situ and induce suppressive immunity. (Keyword) Animals / Base Sequence / Biolistics / Cell Line, Tumor / Dendritic Cells / female / Fibrosarcoma / gene expression / gene therapy / Membrane Proteins / Mice / Mice, Inbred C57BL / RNA, Messenger / Transfection (Tokushima University Institutional Repository) ● Metadata: 83931 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.58.39 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 21372485 ● Summary page in Scopus @ Elsevier: 2-s2.0-79951938597 (Tokushima University Institutional Repository: 83931, DOI: 10.2152/jmi.58.39, PubMed: 21372485, Elsevier: Scopus)
20.	Kanako Yoshida, Takeshi Katou, Yuu Tanaka, Satoshi Yamamoto, Akira Kuwahara, Toshiya Matsuzaki and Minoru Irahara : 当科における子宮内膜症性嚢胞を伴う不妊症患者に対する手術療法の検討, 日本エンドメトリオーシス学会会誌, Vol.32, 106-108, 2011. (Tokushima University Institutional Repository) ● Metadata: 113616 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1050865122806425344 (Tokushima University Institutional Repository: 113616, CiNii: 1050865122806425344)
21.	Kanako Yoshida, Takeshi Katou, Yuri Yamamoto, Yuu Tanaka and Minoru Irahara : 骨盤内膿瘍に対する腹腔鏡手術の有用性, Modern Trends in Obstetrics & Gynecology, Vol.59, No.1, 59-63, 2010. (Summary) 骨盤内膿瘍に対する治療は，抗生剤による薬物療法が主体であるが，抗生剤無効例や，消化管から発生した膿瘍との鑑別を要する症例では外科的アプローチが必要となる．骨盤内膿瘍の場合，炎症による癒着が強いことが多く，手術は比較的難易度が高い．しかし，高度の炎症で疲弊した患者の負担を軽減するために，近年では腹腔鏡手術が積極的に導入されており，当院でも可能な限り腹腔鏡手術で対応している．抗生剤による治療が無効であった付属器膿瘍に対して腹腔鏡下手術を施行した4症例について報告する．4例とも輸血を要するような出血はなく，また他臓器損傷もなかった．術後は，速やかに炎症所見が改善し特に問題なく経過した．骨盤内膿瘍に対する腹腔鏡手術は，ドレナージによりすみやかな炎症軽減が可能であり，かつ低侵襲であることから有用性は高い．一方で，(汎発性腹膜炎などで，)腸管麻痺を伴う症例では，腸管の膨隆のため腹腔鏡下の視野確保が困難であり，腹腔鏡手術の適応は慎重であるべきであると考える． (Keyword) 付属器膿瘍 / 腹腔鏡 / tubo-ovaruan abscess / laparoscopic surgery (Tokushima University Institutional Repository) ● Metadata: 113614 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1050302172853004160 (Tokushima University Institutional Repository: 113614, CiNii: 1050302172853004160)
22.	柴田真紀, Takeshi Katou, Kanako Yoshida, Miki Satou, Yuu Tanaka and Minoru Irahara : 妊娠初期に捻転を起こし腹腔鏡下手術を行ったmassive ovarian edema の一例, Modern Trends in Obstetrics & Gynecology, Vol.59, No.1, 55-57, 2010. (Keyword) 急性腹症 / Massive ovarian edema torsion laparoscopy (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520009409865699968 (CiNii: 1520009409865699968)

Academic Paper (Unrefereed Paper):

1.	Takeshi Iwasa, Hiroki Noguchi, Risa Tanano, Erika Yamanaka, Asuka Takeda, Kou Tamura, Hidenori Aoki, Tatsuro Sugimoto, Hikari Sasada, Takaaki Maeda, Saki Minato, Shota Yamamoto, Hiroaki Inui, Tomohiro Kagawa, Atsuko Yoshida, Ayuka Mineda, Mari Nii, Riyo Kinouchi, Kanako Yoshida, Yuri Yamamoto and Takashi Kaji : Age-Dependent Changes in the Effects of Androgens on Female Metabolic and Body Weight Regulation Systems in Humans and Laboratory Animals., International Journal of Molecular Sciences, Vol.24, No.23, 16567, 2023. (Summary) In recent years, the effects of androgens on metabolic and body weight regulation systems and their underlying mechanisms have been gradually revealed in females. In women and experimental animals of reproductive age, androgen excess can adversely affect metabolic functioning, appetite, and body weight regulation. In addition, excess androgens can increase the risk of metabolic disorders, such as obesity, insulin resistance, and diabetes. These unfavorable effects of androgens are induced by alterations in the actions of hypothalamic appetite-regulatory factors, reductions in energy expenditure, insulin resistance in skeletal muscle, and β-cell dysfunction. Interestingly, these unfavorable effects of androgens on metabolic and body-weight regulation systems are neither observed nor evident in ovariectomized animals and post-menopausal women, indicating that the adverse effects of androgens might be dependent on the estrogen milieu. Recent findings may provide novel sex- and age-specific strategies for treating metabolic diseases. (Keyword) Animals / Humans / female / Androgens / Insulin Resistance / Obesity / Metabolic Diseases / Animals, Laboratory / Polycystic Ovary Syndrome (Link to Publication Site) ● Publication site (DOI): 10.3390/ijms242316567 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 38068890 ● Search Scopus @ Elsevier (PMID): 38068890 ● Search Scopus @ Elsevier (DOI): 10.3390/ijms242316567 (DOI: 10.3390/ijms242316567, PubMed: 38068890)
2.	Ryosuke Arakaki, Kanako Yoshida, Junki Imaizumi, Takashi Kaji, Takeshi Kato and Takeshi Iwasa : Obstructed hemivagina and ipsilateral renal agenesis (OHVIRA) syndrome: A case report., International Journal of Surgery Case Reports, Vol.107, 108368, 2023. (Summary) We report that a combined laparoscopic and transvaginal approach was useful for treating OHVIRA with oviductal hematoma. (Link to Publication Site) ● Publication site (DOI): 10.1016/j.ijscr.2023.108368 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 37295244 ● Search Scopus @ Elsevier (PMID): 37295244 ● Search Scopus @ Elsevier (DOI): 10.1016/j.ijscr.2023.108368 (DOI: 10.1016/j.ijscr.2023.108368, PubMed: 37295244)
3.	Takako Kawakita, Takeshi Katou, Yuri Kadota, 笠井可菜, Kanako Yoshida, Minoru Irahara and Takeshi Iwasa : 当院産科婦人科外来の乳がん検診の現状, 徳島産婦人科医報, No.54, 4-8, 2021.
4.	Takako Kawakita, Takeshi Katou, Yuri Kadota, 笠井可菜, Kanako Yoshida and Minoru Irahara : 子宮腺筋症，子宮内膜症のホルモン剤内服中に発見された乳癌4症例の後方視的検討, 日本産婦人科乳腺医学会雑誌, No.4, 42-46, 2021.

Review, Commentary:

1.	Kanako Yoshida, 村山美咲, 笹田ひかり, Yuri Kadota, 河北貴子, Riyo Kinouchi, 加藤剛志 and Takeshi Iwasa : 特集子宮内膜症の病態と画像診断 -温故知新子宮内膜症·子宮腺筋症の病態,産婦人科的診断と治療戦略, Japanese Journal of Imaging Diagnosis, Vol.43, No.8, 751-758, Jun. 2023. (Link to Publication Site) ● Publication site (DOI): 10.15105/gz.0000004702 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390015191535948032 ● Search Scopus @ Elsevier (DOI): 10.15105/gz.0000004702 (DOI: 10.15105/gz.0000004702, CiNii: 1390015191535948032)
2.	Aya Shirakawa, Kanako Yoshida, 村山美咲, Junki Imaizumi, Tomohiro Kagawa, Takako Kawakita, Takeshi Katou and Takeshi Iwasa : 腹腔鏡下手術を契機に発見した腹膜黒色色素沈着の一例, Japanese Journal of Gynecologic and Obstetric Endoscopy, Vol.38, No.2, 157-161, Aug. 2022. (Tokushima University Institutional Repository) ● Metadata: 118525 (Tokushima University Institutional Repository: 118525)
3.	片山幸子, 河北貴子, 笠井可菜, Kanako Yoshida, Takeshi Katou and Takeshi Iwasa : プレコンセプションケアの観点からみた子宮腺筋症合併妊娠6症例の後方視的検討, 日本エンドメトリオーシス学会雑誌, No.43, 47-51, 2022. (Tokushima University Institutional Repository) ● Metadata: 118524 (Tokushima University Institutional Repository: 118524)
4.	Toshiyuki Yasui, Takako Kawakita, Kanako Yoshida and Takeshi Iwasa : 女性医学から見た脂質代謝異常, Hormone Frontier in Gynecology, Vol.28, No.4, 289-298, Dec. 2021. (Keyword) 脂質代謝異常 / 多囊胞性卵巣症候群 (PCOS) / 閉経 / 子宮内膜症 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520294020601469824 (CiNii: 1520294020601469824)
5.	Toshiyuki Yasui, Takako Kawakita, Kanako Yoshida and Takeshi Iwasa : カウフマン療法, Clinical Gynecology and Obstetrics, Vol.75, No.11, 1033-1037, Nov. 2021.
6.	Toshiyuki Yasui, Takako Kawakita, Kanako Yoshida and Takeshi Iwasa : 内分泌疾患における類薬の使い分け, 糖尿病・内分泌代謝内科, Vol.53, No.1, 56-64, 2021.
7.	Toshiyuki Yasui, Yukie Matsuura, Takako Kawakita, Kanako Yoshida and Takeshi Iwasa : 女性の健康と性ホルモン, 老年医学, Vol.59, No.1, 67-74, 2021.
8.	Toshiyuki Yasui, Yukie Matsuura, Takako Kawakita, Kanako Yoshida and Takeshi Iwasa : 不妊治療における漢方の作用機序, 漢方と最新治療, Vol.29, No.4, 221-228, Nov. 2020. (Keyword) infertility / mechanism / Kampo medicine (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1521980706039341440 (CiNii: 1521980706039341440)
9.	Toshiyuki Yasui, Yukie Matsuura, Takako Kawakita and Kanako Yoshida : OC・LEPの有害事象, Japanese Journal of Medicine and Pharmaceutical Science, Vol.77, No.10, 1367-1374, 2020.

Proceeding of Domestic Conference:

1.	Yoshie Imai, 大川恵, 日下咲, 下川亜矢, 納富理絵, 松本仁美, Akiko Abe, Kanako Yoshida, 村上好恵, 武田祐子 and 川崎優子 : 遺伝性乳がん卵巣がん症候群と診断された乳がん罹患患者のリスク低減卵管卵巣摘出術後の意思決定の様相, 第30回日本遺伝性腫瘍学会学術集会, May 2024.
2.	Hiroaki Inui, 西村正人, 新垣亮輔, Tomohiro Kagawa, Ayuka Mineda, Kanako Yoshida, 加藤剛志 and Takeshi Iwasa : 当院で診断的円錐切除術を施行した子宮頸癌合併妊娠2例の子宮頸部細胞診についての検討, 徳島臨床細胞学会学術集会, Mar. 2024.
3.	Yoshie Imai, 大川恵, 日下咲, 下川亜矢, 納富理絵, 松本仁美, Akiko Abe, Kanako Yoshida, 村上好恵, 武田祐子, 川崎優子, Yuka Mori and 阪本朋香 : 遺伝性乳がん卵巣がん症候群と診断された乳がん罹患患者のリスク低減卵管卵巣摘出術前の意思決定の様相, 第38回日本がん看護学会学術集会, Feb. 2024.
4.	Riyo Kinouchi, 加藤剛志, Asuka Takeda, 内芝舞実, Yuri Kadota, Kanako Yoshida, Toshiyuki Yasui, Minoru Irahara and Takeshi Iwasa : 骨盤臓器脱に対し単一前方メッシュを用いた仙骨膣固定術によるPーQOLの改善についての検討, 第38回日本女性医学学会学術集会, Dec. 2023.
5.	Kanako Yoshida, 加藤剛志 and Takeshi Iwasa : シンポジウム:「周閉経期以降の子宮筋腫，子宮内膜症，子宮腺筋症への対応を考える」周閉経期以降の子宮筋腫の管理, 第38回日本女性医学学会学術集会, Dec. 2023.
6.	Kanako Yoshida : 更年期を上手にのりきるために「尿のトラブル(頻尿，尿もれ)解消法)」, 第1 回女性が素敵に生きるための市民公開講座, Nov. 2023.
7.	Riyo Kinouchi, 加藤剛志, Asuka Takeda, 新垣亮輔, 内芝舞実, Tomohiro Kagawa, 白河綾, Ayuka Mineda, Yuri Yamamoto, Kanako Yoshida and Takeshi Iwasa : 前方シングルメッシュによるLSCまたはRSCによるPーQOLの改善についての検討, 第75回中国四国産科婦人科学会総会ならびに学術講演会, Sep. 2023.
8.	Riyo Kinouchi, 加藤剛志, Asuka Takeda, 新垣亮輔, 内芝舞実, Tomohiro Kagawa, 白河綾, Ayuka Mineda, Yuri Yamamoto, Kanako Yoshida and Takeshi Iwasa : 前方シングルメッシュによるLSCまたはRSCによるP-QOLの改善についての検討, 第63回日本産科婦人科内視鏡学会学術講演会, Sep. 2023.
9.	Kanako Yoshida and Takeshi Katou : ワークショップ: 当科におけるTLH習得に向けての教育法の工夫, 第35回日本内視鏡外科学会, Dec. 2022.
10.	Kanako Yoshida : 管理者・指導者に聞く医師の働き方改革への取り組み「徳島県における医師の働き方改革への取り組み」, 日本産婦人科医会令和4年度勤務医懇話会, Oct. 2022.
11.	Kanako Yoshida, Takeshi Katou, 武田明日香, Ryosuke Arakaki, 今泉絢貴, Tomohiro Kagawa, Ayuka Mineda, 河北貴子, Yuri Yamamoto, 苛原稔 and Takeshi Iwasa : ワークショップ:効率よくTLH上達を目指すための当科での取り組み, 第62回日本産婦人科内視鏡学会, Sep. 2022.
12.	Kanako Yoshida : 徳島県における子宮頸がん予防の現状, HPVワクチンセミナー in 徳島, Apr. 2022.
13.	Kanako Yoshida, Yuri Kadota, Kana Kasai, Ayuka Mineda, Takako Kawakita, Takeshi Katou, Masato Nishimura, Minoru Irahara and Takeshi Iwasa : 腹腔鏡下仙骨腟固定術(LSC)における後腹膜閉鎖の工夫, 第60回日本産婦人科内視鏡学会学術講演会, Dec. 2020.
14.	Kanako Yoshida, Takeshi Katou, Yuri Kadota, Kana Kasai, Takako Kawakita, 桑原章 and Minoru Irahara : 当科における腹腔鏡下仙骨腟固定術(LSC)導入の現状, 第72回日本産科婦人科学会学術講演会, Apr. 2020.
15.	圓藤幸子, Takako Kawakita, 祖川英至, Yuri Kadota, 笠井可菜, Takeshi Iwasa, Kanako Yoshida, Takeshi Katou, Takashi Kaji and Minoru Irahara : コンセプションケアからみた不妊治療後の子宮腺筋症合併妊娠の妊娠予後の検討, 第72回日本産科婦人科学会学術集会, Apr. 2020.
16.	Masato Nishimura, Ayuka Mineda, Akiko Abe, Kanako Yoshida, Takeshi Katou and Minoru Irahara : 若年におけるHPVワクチン接種は子宮頸癌検診における細胞診異常の頻度を低下させる, 第60回日本臨床細胞学会学術講演会, Jun. 2019.
17.	Kanako Yoshida, 門田友里, Kana Kasai, Takako Kawakita, Takeshi Katou and Minoru Irahara : 妊娠中の腹腔鏡下卵巣腫瘍手術におけるアプローチ法の工夫, The Journal of Japan Society for Menopause and Women's Health, Vol.26, Oct. 2018.
18.	Kanako Yoshida, Kadota Yuri, Kasai Kana, Kawakita Takako, Takeshi Katou and Minoru Irahara : Healthcare for young gynecologic malignant tumor patients at our hospital, Acta Obstetrica et Gynaecologica Japonica, Vol.70, No.2, 637, Feb. 2018.
19.	Kanako Yoshida, 門田友里, Kana Kasai, Takako Kawakita, Takeshi Katou and Minoru Irahara : 妊娠中の腹腔鏡下卵巣腫瘍手術におけるアプローチ法の工夫, Japanese Journal of Gynecologic and Obstetric Endoscopy, Vol.34, 2018.
20.	松井寿美佳, Toshiyuki Yasui, Kana Kasai, Kanako Yoshida, Takeshi Katou, Hirokazu Uemura and Minoru Irahara : ホルモン補充療法中，デヒドロエピアンドロステロンサルフェートは，わずかなエストロゲンの増加でも低下する, 第32回日本女性医学学会学術集会, Nov. 2017.
21.	Kanako Yoshida : ワークショップ:深部子宮内膜症に対する治療戦略子宮腺筋症患者における術前MRIによる深部子宮内膜症の評価, 第29回日本内視鏡外科学会総会, Dec. 2016.
22.	Takeshi Katou, Kaoru Keyama, Takako Kawakita, 谷杏奈, Sumika Matsui, Kanako Yoshida, Masato Nishimura, Hirokazu Uemura, Toshiyuki Yasui and Minoru Irahara : P2-31-8 当院におけるがん患者に対するHRT施行の現状(Group 69 更年期・老年期・閉経1,一般演題,第66回学術講演会), Acta Obstetrica et Gynaecologica Japonica, Vol.66, No.2, 665, Feb. 2014. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1541698620249180800 (CiNii: 1541698620249180800)
23.	Kanako Yoshida : 婦人科がんにおける妊孕性温存治療, 第44回徳島母性衛生学会, Sep. 2012.
24.	Kanako Yoshida, Takeshi Katou, Masato Nishimura, 古本博孝 and Minoru Irahara : シンポジウム:子宮頸癌における腺系異常, 第27回日本臨床細胞学会中国四国連合会総会・学術集会, Jul. 2012.
25.	Masato Nishimura, 古本博孝, Kanako Yoshida and Minoru Irahara : 支部長推薦演題:幽門腺化生∼悪性腺腫の頸管粘液中の胃型ムチンと細胞像, 第53回日本臨床細胞学会(春期大会), Jun. 2012.
26.	Kanako Yoshida : 子宮頸がんは予防する時代に, おぎゃっと21, May 2012.
27.	Kanako Yoshida, 東元あゆか, Akiko Abe, 海老沢桂子, Takeshi Katou, Masato Nishimura, Hiroyuki Furumoto and Minoru Irahara : ワークショップ: 子宮体癌新FIGO分類pTla期に対するリンパ節郭清の必要性について, 第50回日本婦人科腫瘍学会学術講演会, Jul. 2011.

Et cetera, Workshop:

1.	Kanako Yoshida : 特別講演:婦人科がん治療後のヘルスケアにおける現状と課題, FUJI women's health regional webinar, Oct. 2021.
2.	Takako Kawakita, Takeshi Katou, Yuri Kadota, 笠井可菜, Kanako Yoshida and Minoru Irahara : International Session Workshop : New mouse model of uterine adenomyosis., 第72回日本産科婦人科学会学術講演会, Apr. 2021.
3.	Kanako Yoshida : 教育講演: 子宮内膜症の治療における手術療法と薬物療法, 第64回徳島不妊・内分泌研究会, Feb. 2019.
4.	Kanako Yoshida : パネルディスカッション: 高齢出産時代の女性のからだとキャリア形成, 平成24年度徳島産科婦人科学会市民公開講座, Mar. 2013.
5.	Masato Nishimura, Hiroyuki Furumoto, 東元あゆか, Kanako Yoshida and Minoru Irahara : シンポジウム: 幽門腺化生∼悪性腺腫の頸管粘液中の胃型ムチンと細胞像, 第26回日本臨床細胞学会中国四国連合会学術集会, Jul. 2011.

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)

Search by Researcher Number (30572127)

Associate Professor : Yoshida, Kanako

Research

Field of Study

Subject of Study

Book / Paper

Book:

Academic Paper (Judged Full Paper):

Academic Paper (Unrefereed Paper):

Review, Commentary:

Proceeding of Domestic Conference:

Et cetera, Workshop:

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)